Valued at $439.0M at its early-stage round, Nov 2025. Nothing has traded since.
- ·The complete investor list: 16 names
- ·Watch Solve Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Solve Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC | $48.2M | ▮ | ▮ |
| Dec 2024 | Later Stage VC | $50.4M | ▮ | ▮ |
| Dec 2021 | Later Stage VC | $63.5M | ▮ | ▮ |
Membership and data by Private Market View
Solve Therapeutics valuation
Solve Therapeutics was valued at $439 million at its early-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Solve Therapeutics raised?
Solve Therapeutics has raised $385 million in total; 3 of its rounds are on record, from 2021 on. The largest on record was a $63.5 million later-stage round in Dec 2021; the most recent was a $48.2 million early-stage round in Nov 2025.
Solve Therapeutics has filed 3 Form Ds with the SEC since 2022, most recently in Nov 2025 ($48.2 million sold to 16 investors).
How Solve Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Solve Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Solve Therapeutics
- What is Solve Therapeutics worth?
- Solve Therapeutics is valued at $439.0M as of Oct 2026. Valued at $439.0M at its early-stage round, Nov 2025. Nothing has traded since.
- How much has Solve Therapeutics raised?
- Solve Therapeutics has raised $384.5M in total funding across 3 recorded rounds.
- When did Solve Therapeutics last raise?
- Solve Therapeutics last raised in Nov 2025 (Early Stage VC), raising $48.2M.